Does the molecular classification of breast cancer point the way for biomarker identification in prostate cancer?
Authors:
- William J F GreenWGWilliam J F Green
- Graham BallGBGraham Ball
- Des PoweDPDes Powe
Open Access
- 1 January 2016
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Urology
- Vol. 5 (2) , 80
Abstract
Does the molecular classification of breast cancer point the way for biomarker identification in prostate cancer?Keywords
This publication has 84 references indexed in Scilit:
- HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trialsCancer Treatment Reviews, 2013
- Epithelial Cell Adhesion Molecule-positive Circulating Tumor Cells as Predictive Biomarker in Patients With Prostate CancerUrology, 2013
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2013
- Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneityNature Cell Biology, 2013
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohortBritish Journal of Cancer, 2012
- Transcription factor Dlx2 protects from TGFβ‐induced cell‐cycle arrest and apoptosisThe EMBO Journal, 2011
- Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical ProstatectomyJournal of Urology, 2010
- A luminal epithelial stem cell that is a cell of origin for prostate cancerNature, 2009
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- Role of the stromal microenvironment in carcinogenesis of the prostateInternational Journal of Cancer, 2003